- Title
- Expanding the genetic basis of copy number variation in familial breast cancer
- Creator
- Masson, Amy L.; Talseth-Palmer, Bente A.; Evans, Tiffany-Jane; Grice, Desma M.; Hannan, Garry N.; Scott, Rodney J.
- Relation
- Hereditary Cancer in Clinical Practice Vol. 12
- Publisher Link
- http://dx.doi.org/10.1186/1897-4287-12-15
- Publisher
- BioMed Central
- Resource Type
- journal article
- Date
- 2014
- Description
- Introduction: Familial breast cancer (fBC) is generally associated with an early age of diagnosis and a higher frequency of disease among family members. Over the past two decades a number of genes have been identified that are unequivocally associated with breast cancer (BC) risk but there remain a significant proportion of families that cannot be accounted for by these genes. Copy number variants (CNVs) are a form of genetic variation yet to be fully explored for their contribution to fBC. CNVs exert their effects by either being associated with whole or partial gene deletions or duplications and by interrupting epigenetic patterning thereby contributing to disease development. CNV analysis can also be used to identify new genes and loci which may be associated with disease risk. Methods: The Affymetrix Cytogenetic Whole Genome 2.7 M (Cyto2.7 M) arrays were used to detect regions of genomic re-arrangement in a cohort of 129 fBC BRCA1/BRCA2 mutation negative patients with a young age of diagnosis (<50 years) compared to 40 unaffected healthy controls (>55 years of age). Results: CNV analysis revealed the presence of 275 unique rearrangements that were not present in the control population suggestive of their involvement in BC risk. Several CNVs were found that have been previously reported as BC susceptibility genes. This included CNVs in RPA3, NBN (NBS1), MRE11A and CYP19A1 in five unrelated fBC patients suggesting that these genes are involved in BC initiation and/or progression. Of special interest was the identification of WWOX and FHIT rearrangements in three unrelated fBC patients. Conclusions: This study has identified a number of CNVs that potentially contribute to BC initiation and/or progression. The identification of CNVs that are associated with known tumour suppressor genes is of special interest that warrants further larger studies to understand their precise role in fBC.
- Subject
- breast cancer; DNA repair; CNV
- Identifier
- http://hdl.handle.net/1959.13/1060526
- Identifier
- uon:16788
- Identifier
- ISSN:1731-2302
- Language
- eng
- Full Text
- Reviewed
- Hits: 4920
- Visitors: 3038
- Downloads: 398
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | ATTACHMENT01 | Publisher version (open access) | 812 KB | Adobe Acrobat PDF | View Details Download |